CRBU Caribou Biosciences, Inc. - Common Stock
$1,99
Prix · Mai 22, 2026
Données fondamentales au Mai 7, 2026
Fourchette 52 semaines
$1–$4
40% of range
Note des analystes
BUY
15 analysts
Objectif de cours
$12
+502% upside
P/E (TTM)
-1.0
ROE
-102.8%
Marge nette
-1327.4%
CRBU Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.99
Capitalisation Boursière
$151M
P/E (TTM)
-1.0
BPA (TTM)
$-1.59
Revenus (TTM)
$11M
Rendement div.
—
ROE
-102.8%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $4
CRBU Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$11M
2019-12-31
→
2025-12-31
BPA
$-1.59
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-112M
2021-12-31
→
2025-12-31
Marges
-1327.4%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CRBU
Médiane des pairs
P/E (TTM)
-1.0
2.4
P/S (TTM)
13.6
15.2
P/B
1.2
1.4
Price / FCF (Cours / FCF)
-1.3
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CRBU
Médiane des pairs
Operating Margin (Marge d'exploitation)
-1329.4%
—
Net Profit Margin (Marge nette)
-1327.4%
-946.2%
ROA
-60.6%
-52.8%
ROE
-102.8%
-60.2%
ROIC
-121.0%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CRBU
Médiane des pairs
Current Ratio (Ratio de liquidité)
5.7
7.4
Quick Ratio (Ratio de liquidité réduite)
0.5
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CRBU
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
11.7%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-7.0%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
-2.0%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CRBU
Médiane des pairs
CRBU Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 5 33,3%
- Achat 9 60,0%
- Conserver 1 6,7%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
7 analystes · 2026-05-22
Médiane
$10.00
← En dessous de tous les objectifs
$1.99
Bas
$4.00
Haut
$32.00
Objectif médian
$10.00
+401,5%
Objectif moyen
$12.00
+501,8%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.00%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.26 | $-0.32 | 0.06% |
| 31 décembre 2025 | $-0.28 | $-0.32 | 0.04% |
| 30 septembre 2025 | $-0.30 | $-0.37 | 0.07% |
| 30 juin 2025 | $-0.58 | $-0.40 | -0.18% |
| 31 mars 2025 | $-0.43 | $-0.45 | 0.02% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| NBP | — | — | — | — | — | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| ELTX | — | -3.1 | — | — | — | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11M | $10M | $34M | $14M | $10M | $12M | |
| R&D Expense | $109M | $130M | $112M | $82M | $52M | $34M | |
| SG&A Expense | $38M | $46M | $38M | $38M | $24M | $14M | |
| Operating Expenses | $160M | $177M | $151M | $120M | $77M | $48M | |
| Operating Income | $-148M | $-167M | $-116M | $-106M | $-67M | $-36M | |
| Interest Expense | · | · | · | · | $8.0K | $20.0K | |
| Other Non-op | $-331.0K | $18M | $14M | $7M | $377.0K | $-3.0K | |
| Pretax Income | $-149M | $-149M | $-102M | $-99M | $-67M | $-36M | |
| Income Tax | $-550.0K | $-9.0K | $193.0K | $70.0K | $321.0K | $-2M | |
| Net Income | $-148M | $-149M | $-102M | $-99M | $-67M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| Shares (Basic) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| Shares (Diluted) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| EBITDA | $-145M | $-163M | $-113M | $-105M | $-66M | · |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $16M | $51M | $58M | $240M | $16M | |
| Short-term Investments | · | · | · | · | $135M | $0 | |
| Receivables | $69.0K | $265.0K | $148.0K | $202.0K | $1M | $150.0K | |
| Prepaid Expense | $3M | $7M | $6M | $8M | $7M | $3M | |
| Current Assets | $145M | $219M | $339M | $260M | $391M | $24M | |
| PP&E (Net) | $7M | $19M | $18M | $11M | $5M | $4M | |
| PP&E (Gross) | $20M | $32M | $27M | $16M | $9M | $7M | |
| Accum. Depreciation | $14M | $13M | $9M | $6M | $4M | $3M | |
| Other Non-current Assets | $2M | $6M | $2M | $2M | $975.0K | $612.0K | |
| Total Assets | $175M | $313M | $432M | $374M | $442M | $36M | |
| Accounts Payable | $6M | $2M | $3M | $1M | $4M | $3M | |
| Accrued Liabilities | $17M | $24M | $21M | $16M | $13M | $9M | |
| Current Liabilities | $25M | $31M | $28M | $28M | $26M | $12M | |
| Capital Leases | $26M | $25M | $26M | $27M | $0 | · | |
| Deferred Tax | $0 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Total Liabilities | $53M | $60M | $64M | $73M | $55M | $18M | |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | |
| Paid-in Capital | $719M | $701M | $668M | $500M | $486M | $7M | |
| Retained Earnings | $-597M | $-448M | $-299M | $-197M | $-98M | $-31M | |
| AOCI | $103.0K | $255.0K | $30.0K | $-2M | $-135.0K | $0 | |
| Stockholders' Equity | $122M | $253M | $368M | $301M | $388M | $-23M | |
| Liabilities + Equity | $175M | $313M | $432M | $374M | $442M | $36M | |
| Shares Outstanding | 95,143,690 | 92,378,577 | 88,448,948 | 61,029,184 | 60,263,158 | 9,710,829 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $2M | $984.0K | $900.0K | |
| Stock-based Comp | $13M | $17M | $14M | $12M | $3M | $1M | |
| Deferred Tax | $-551.0K | $-10.0K | $178.0K | $-95.0K | $320.0K | $-919.0K | |
| Other Non-cash | $21M | $-10M | $-9M | $-5M | $30M | · | |
| Operating Cash Flow | $-111M | $-138M | $-93M | $-91M | $-33M | $-33M | |
| CapEx | $1M | $5M | $12M | $6M | $2M | $317.0K | |
| Investing Cash Flow | $102M | $87M | $-68M | $-93M | $-176M | $6M | |
| Stock Issued | $4M | $15M | $1M | $0 | · | · | |
| Net Stock Activity | $4M | $15M | $1M | · | · | · | |
| Financing Cash Flow | $5M | $17M | $154M | $2M | $433M | $2M | |
| Net Change in Cash | $-4M | $-35M | $-7M | $-182M | $225M | $-25M | |
| Taxes Paid | · | $0 | $170.0K | $0 | $11.0K | $21.0K | |
| Free Cash Flow | $-112M | $-143M | $-105M | $-97M | $-35M | · | |
| Levered FCF | · | · | · | · | $-35M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | · | |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | · | |
| Pretax Margin | -1332.3% | -1492.0% | -295.5% | -717.3% | -693.9% | · | |
| EBITDA Margin | -1296.7% | -1627.9% | -326.4% | -756.5% | -687.6% | · | |
| ROA | -60.6% | -40.0% | -25.3% | -24.4% | -28.0% | · | |
| ROE | -102.8% | -55.8% | -26.6% | -31.8% | -16.9% | · | |
| ROIC | -121.0% | -65.9% | -31.6% | -35.4% | -17.3% | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 | · | |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 | · | |
| Interest Coverage | · | · | · | · | -8372.4 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | |
| Receivables Turnover | 66.8 | 48.4 | 197.0 | 20.4 | 14.7 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% | · | |
| Revenue CAGR 3Y | -7.0% | 1.4% | 40.8% | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $10M | $34M | $14M | $10M | · | |
| Net Income TTM | $-148M | $-149M | $-102M | $-99M | $-67M | · | |
| Market Cap | $151M | $147M | $507M | $383M | $909M | · | |
| P/E | -1.0 | -1.0 | -4.2 | -3.8 | -7.2 | · | |
| P/S | 13.6 | 14.7 | 14.7 | 27.7 | 94.7 | · | |
| P/B | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Tangible Book | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Cash Flow | -1.4 | -1.1 | -5.4 | -4.2 | -28.0 | · | |
| P / FCF | -1.3 | -1.0 | -4.8 | -3.9 | -26.3 | · | |
| Earnings Yield | -100.0% | -103.8% | -24.1% | -26.1% | -14.0% | · |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $4M | $24M | $4M | $4M | $4M | $3M | $4M | |
| R&D Expense | $21M | $24M | $22M | $28M | $36M | $30M | $30M | $35M | $34M | $31M | $29M | $27M | $26M | $26M | $20M | $23M | |
| SG&A Expense | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $15M | $10M | $10M | $10M | $9M | $9M | $10M | $10M | |
| Operating Expenses | $29M | $32M | $32M | $50M | $45M | $41M | $40M | $47M | $48M | $41M | $38M | $37M | $35M | $34M | $30M | $33M | |
| Operating Income | $-26M | $-28M | $-29M | $-48M | $-43M | $-39M | $-38M | $-44M | $-46M | $-37M | $-15M | $-33M | $-31M | $-31M | $-27M | $-28M | |
| Other Non-op | $1M | $1M | $2M | $-7M | $3M | $3M | $4M | $6M | $5M | $3M | $5M | $3M | $3M | $4M | $-110.0K | $2M | |
| Income Tax | $0 | $-550.0K | $0 | · | $0 | $-9.0K | $0 | $0 | $0 | $193.0K | $0 | $0 | $0 | $70.0K | $0 | $0 | |
| Net Income | $-25M | $-26M | $-28M | $-54M | $-40M | $-35M | $-35M | $-38M | $-41M | $-35M | $-10M | $-30M | $-28M | $-27M | $-27M | $-27M | |
| EPS (Basic) | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | $-0.44 | |
| EPS (Diluted) | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | $-0.44 | |
| Shares (Basic) | 95,861,716 | -185,612,007 | 93,293,099 | 93,028,698 | 92,679,493 | -179,781,844 | 90,455,900 | 90,340,932 | 89,302,937 | -132,580,843 | 83,783,992 | 61,417,934 | 61,186,514 | -121,389,647 | 60,886,921 | 60,757,689 | |
| Shares (Diluted) | 95,861,716 | -185,612,007 | 93,293,099 | 93,028,698 | 92,679,493 | -179,781,844 | 90,455,900 | 90,340,932 | 89,302,937 | -132,580,843 | 83,783,992 | 61,417,934 | 61,186,514 | -121,389,647 | 60,886,921 | 60,757,689 | |
| EBITDA | $-26M | · | $-29M | $-48M | $-42M | · | $-38M | $-44M | $-45M | · | $-15M | · | · | · | $-27M | $-28M |
Bilan 23
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $12M | $11M | $25M | $29M | $16M | $32M | $38M | $49M | $51M | $104M | $66M | $53M | $58M | $82M | $112M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $228M | |
| Receivables | $227.0K | $69.0K | $242.0K | $71.0K | $88.0K | $265.0K | $184.0K | $215.0K | $917.0K | $148.0K | $1M | $766.0K | $2M | $202.0K | $397.0K | $524.0K | |
| Prepaid Expense | $2M | $3M | $5M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | $7M | $6M | $6M | $8M | $9M | $7M | |
| Current Assets | $122M | $145M | $156M | $193M | $217M | $219M | $237M | $271M | $305M | $339M | $351M | $269M | $239M | $260M | $307M | $353M | |
| PP&E (Net) | $6M | $7M | $8M | $8M | $19M | $19M | $20M | $20M | $19M | $18M | $17M | $15M | $13M | $11M | $9M | $8M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $33M | $32M | $31M | $31M | $29M | $27M | $25M | $22M | $19M | $16M | $14M | $13M | |
| Accum. Depreciation | $14M | $14M | $13M | $12M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | $5M | |
| Other Non-current Assets | $2M | $2M | $4M | $4M | $5M | $6M | $5M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | |
| Total Assets | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | $421M | |
| Accounts Payable | $4M | $6M | $4M | $3M | $4M | $2M | $3M | $3M | $6M | $3M | $2M | $4M | $3M | $1M | $1M | $426.0K | |
| Accrued Liabilities | $14M | $17M | $19M | $21M | $20M | $24M | $25M | $24M | $19M | $21M | $18M | $16M | $13M | $16M | $15M | $15M | |
| Current Liabilities | $20M | $25M | $28M | $29M | $28M | $31M | $32M | $31M | $29M | $28M | $25M | $34M | $27M | $28M | $29M | $29M | |
| Capital Leases | $26M | $26M | $23M | $24M | $24M | $25M | $25M | $26M | $26M | $26M | $26M | $26M | $26M | $27M | $27M | $27M | |
| Deferred Tax | · | $0 | $548.0K | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $557.0K | $381.0K | $380.0K | $382.0K | $381.0K | $475.0K | $475.0K | |
| Total Liabilities | $47M | $53M | $53M | $55M | $56M | $60M | $63M | $62M | $64M | $64M | $59M | $80M | $69M | $73M | $75M | $73M | |
| Common Stock | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $724M | $719M | $712M | $709M | $705M | $701M | $693M | $689M | $684M | $668M | $664M | $525M | $504M | $500M | $496M | $493M | |
| Retained Earnings | $-622M | $-597M | $-570M | $-542M | $-488M | $-448M | $-413M | $-378M | $-341M | $-299M | $-265M | $-255M | $-225M | $-197M | $-170M | $-144M | |
| AOCI | $-23.0K | $103.0K | $93.0K | $40.0K | $167.0K | $255.0K | $789.0K | $-319.0K | $-322.0K | $30.0K | $-981.0K | $-1M | $-730.0K | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $102M | $122M | $142M | $166M | $217M | $253M | $281M | $310M | $343M | $368M | $398M | $269M | $278M | $301M | $324M | $348M | |
| Liabilities + Equity | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | $421M | |
| Shares Outstanding | 96,951,234 | 95,143,690 | 93,468,038 | 93,123,239 | 93,004,602 | 92,378,577 | 90,552,687 | 90,362,771 | 90,314,501 | 88,448,948 | 88,430,609 | 66,100,039 | 61,323,523 | 61,029,184 | 60,986,936 | 60,838,370 |
Flux de trésorerie 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $649.0K | $682.0K | $631.0K | $1M | $1M | $1M | $1M | $856.0K | $710.0K | $740.0K | $2M | $617.0K | $589.0K | $506.0K | $450.0K | $358.0K | |
| Stock-based Comp | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-5M | · | · | · | $-2M | · | · | · | $-667.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-27M | $-21M | $-25M | $-28M | $-37M | $-35M | $-33M | $-33M | $-37M | $-21M | $-29M | $-15M | $-28M | $-25M | $-22M | $-22M | |
| CapEx | $72.0K | $-216.0K | $115.0K | $418.0K | $1M | $518.0K | $673.0K | $2M | $1M | $2M | $5M | $3M | $2M | $2M | $1M | $3M | |
| Investing Cash Flow | $24M | $18M | $11M | $24M | $49M | $16M | $27M | $21M | $23M | $-31M | $-68M | $11M | $21M | $1M | $-8M | $-14M | |
| Stock Issued | $2M | $4M | $0 | $0 | $0 | $4M | $0 | $0 | $11M | $0 | $-1.0K | $-115.0K | $1M | $0 | $0 | $0 | |
| Net Stock Activity | $2M | · | · | · | $0 | · | · | · | $11M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $4M | $277.0K | $6.0K | $468.0K | $4M | $244.0K | $132.0K | $12M | $-43.0K | $135M | $18M | $2M | $127.0K | $654.0K | $362.0K | |
| Net Change in Cash | $-303.0K | $1M | $-14M | $-4M | $13M | $-16M | $-6M | $-12M | $-2M | $-53M | $38M | $13M | $-6M | $-24M | $-30M | $-35M | |
| Taxes Paid | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | $0 | |
| Free Cash Flow | $-27M | · | · | · | $-38M | · | · | · | $-39M | · | · | · | · | · | · | · |
Rentabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1096.4% | · | -1337.6% | -1784.0% | -1823.8% | · | -1889.2% | -1255.8% | -1893.9% | · | -61.8% | · | · | · | -803.4% | -678.2% | |
| Net Margin | -1046.5% | · | -1253.3% | -2028.4% | -1699.6% | · | -1713.6% | -1088.2% | -1697.6% | · | -42.3% | · | · | · | -806.8% | -636.9% | |
| EBITDA Margin | -1069.3% | · | -1337.6% | -1784.0% | -1774.2% | · | -1889.2% | -1255.8% | -1864.6% | · | -61.8% | · | · | · | -803.4% | -678.2% | |
| ROA | -11.9% | · | -10.2% | -18.2% | -11.8% | · | -8.6% | -10.4% | -10.9% | · | -2.3% | · | · | · | -6.2% | -9.2% | |
| ROE | -15.7% | · | -13.0% | -22.7% | -14.3% | · | -10.2% | -13.0% | -13.3% | · | -2.8% | · | · | · | -7.3% | -17.8% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | · | 5.5 | 6.7 | 7.6 | · | 7.4 | 8.8 | 10.5 | · | 14.3 | · | · | · | 10.7 | 12.2 | |
| Quick Ratio | 0.6 | · | 0.4 | 0.9 | 1.0 | · | 1.0 | 1.2 | 1.7 | · | 4.3 | · | · | · | 2.9 | 11.8 |
Efficacité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | 15.2 | · | 10.3 | 18.7 | 4.7 | · | 3.1 | 7.1 | 2.0 | · | 30.9 | · | · | · | 6.8 | 15.9 |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | · | $9M | $11M | $10M | · | $32M | $33M | $33M | · | $34M | $15M | $14M | · | $13M | $13M | |
| Net Income TTM | $-147M | · | $-156M | $-166M | $-154M | · | $-124M | $-118M | $-109M | · | $-94M | $-111M | $-100M | · | $-91M | $-85M | |
| Market Cap | $184M | · | $218M | $117M | $85M | · | $177M | $148M | $464M | · | $423M | · | · | · | $643M | $330M | |
| P/E | -1.2 | · | -1.4 | -0.7 | -0.5 | · | -1.4 | -1.1 | -3.4 | · | -3.2 | -2.3 | -3.2 | · | -6.4 | -2.1 | |
| P/S | 19.2 | · | 23.6 | 11.2 | 8.3 | · | 5.6 | 4.4 | 13.9 | · | 12.4 | · | · | · | 50.6 | 24.7 | |
| P/B | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | · | · | · | 2.0 | 0.9 | |
| P / Tangible Book | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | 1.0 | 1.2 | · | 2.0 | 0.9 | |
| P / Cash Flow | -6.8 | · | · | · | -2.3 | · | · | · | -12.5 | · | · | · | · | · | · | · | |
| P / FCF | -6.8 | · | · | · | -2.2 | · | · | · | -12.0 | · | · | · | · | · | · | · | |
| Earnings Yield | -82.6% | · | -72.5% | -143.7% | -185.1% | · | -70.4% | -90.2% | -29.6% | · | -31.4% | -42.8% | -31.3% | · | -15.7% | -48.1% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $11M | $10M | $34M | $14M | $10M |
| Marge d'exploitation % | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| Résultat net | $-148M | $-149M | $-102M | $-99M | $-67M |
| BPA dilué | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 |
| Ratio de liquidité réduite | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-112M | $-143M | $-105M | $-97M | $-35M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.